TP53 and hepatocellular carcinoma: Considering the clinical utility of risk score in predicting OS in patients with TP53 wild-type HCC, we established a Nomograph including model risk score and main clinical features to predict 1-year, 3-year, and 5-year OS rates (Figure 6F).